These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33125137)

  • 1. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer.
    Chen C; Wu H; Kong D; Xu Y; Zhang Z; Chen F; Zou L; Li Z; Shui J; Luo H; Liu SH; Yu J; Wang K; Brunicardi FC
    Oncol Rep; 2020 Dec; 44(6):2569-2580. PubMed ID: 33125137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in statin-induced changes in gene expression profiles of pancreatic cancer.
    Gbelcová H; Rimpelová S; Ruml T; Fenclová M; Kosek V; Hajšlová J; Strnad H; Kolář M; Vítek L
    Sci Rep; 2017 Mar; 7():44219. PubMed ID: 28276528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins decrease the expression of c-Myc protein in cancer cell lines.
    Rao PS; Rao US
    Mol Cell Biochem; 2021 Feb; 476(2):743-755. PubMed ID: 33070276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells.
    Lin CK; Liu ST; Chang CC; Huang SM
    PLoS One; 2019; 14(4):e0214408. PubMed ID: 30939155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins.
    Rimpelová S; Kolář M; Strnad H; Ruml T; Vítek L; Gbelcová H
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Effects of Statins on A549 Nonsmall-Cell Lung Cancer Cell Line Lipids Using Fourier Transform Infrared Spectroscopy: Rosuvastatin Stands Out.
    Aksoy HN; Ceylan C
    Lipids; 2021 May; 56(3):289-299. PubMed ID: 33611813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
    Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
    Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in antitumor effects of various statins on human pancreatic cancer.
    Gbelcová H; Lenícek M; Zelenka J; Knejzlík Z; Dvoráková G; Zadinová M; Poucková P; Kudla M; Balaz P; Ruml T; Vítek L
    Int J Cancer; 2008 Mar; 122(6):1214-21. PubMed ID: 18027870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
    Neuvonen PJ; Backman JT; Niemi M
    Clin Pharmacokinet; 2008; 47(7):463-74. PubMed ID: 18563955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
    Hao F; Xu Q; Wang J; Yu S; Chang HH; Sinnett-Smith J; Eibl G; Rozengurt E
    PLoS One; 2019; 14(5):e0216603. PubMed ID: 31100067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences of statin activity in 2D and 3D pancreatic cancer cell cultures.
    Paškevičiūtė M; Petrikaitė V
    Drug Des Devel Ther; 2017; 11():3273-3280. PubMed ID: 29180851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex.
    Johnson-Anuna LN; Eckert GP; Keller JH; Igbavboa U; Franke C; Fechner T; Schubert-Zsilavecz M; Karas M; Müller WE; Wood WG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):786-93. PubMed ID: 15358814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.